Venue: Walter E. Washington Convention Center, Washington DC
Date:
Apr 03, 2023 - Apr 06, 2023
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain.
If you are involved in vaccines or new to it because of the pandemic, this is the most important meeting you will be part of.
Uniting vaccine experts – sharing groundbreaking knowledge – tackling the pandemic.
You can find us at booth #1012. We will also have a meeting room available (#205). Please feel free to schedule a meeting with us at the button below.
Round Table Date: April 4, 2023 Time: 12:30 PM ET Title: Overcoming hurdles in manufacturing and characterization to achieve a successful mRNA program
Featured Speaker: Khaled Yamout
Senior Director Analytical Services & Quality Control, TriLink BioTechnologies
Featured Presentation Date: April 5, 2023 Time: 12:10 PM ET Title: Considerations for mRNA Vaccine Development
Featured Speaker: Jordana Henderson
Associate Director R&D, TriLink BioTechnologies
Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.
You can find TriLink at booth #TBD.
Featured Presentation Date: May 7, 2023 Time: 12:30 PM PST Title: Next-generation mRNA design – increasing mRNA potency with a new cap analog
Featured Speaker: Kate Broderick, PhD
Chief Innovation Officer, Maravai Life Sciences
Summary: mRNA vaccines and therapeutics are expanding rapidly, in part fueled by the success of COVID-19 vaccines. An essential part of any mRNA therapeutic is the 5’ cap structure, which is critical to the stability and expression of an mRNA. Learn more about how major capping strategies differ in their manufacturing costs, time, complexity, and availability, and how TriLink BioTechnologies is continuing to innovate in this technology as we debut a novel Cap1 structure.
A discussion on the development, manufacturing, and analysis of high-quality DNA & RNA utilizing both cell-based and cell-free processes. This includes the raw materials necessary for in vitro replication and/or transcription with a focus on the acquisition of quality nucleotides and recombinant enzymes as well as the lipids and other components required as part of the nanoparticle delivery system.
Featured Presentation Date: May 9, 2023 Time: 10:30 AM ET Title: TBD
Featured Speaker: Khaled Yamout
Senior Director Analytical Services & Quality Control, TriLink BioTechnologies
